Sun Pharmaceutical Industries Ltd. (SUN)

Currency in INR
1,928.60
-6.90(-0.36%)
Real-time Data·
SUN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,911.001,933.10
52 wk Range
1,548.001,953.90
Key Statistics
Bid/Ask
1,928.70 / 1,929.30
Prev. Close
1,935.5
Open
1,925.9
Day's Range
1,911-1,933.1
52 wk Range
1,548-1,953.9
Volume
896.13K
Average Volume (3m)
3.53M
1-Year Change
15.3768%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SUN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2,055.00
Upside
+6.55%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Analyst Ratings

30 Buy
1 Hold
3 Sell
Ratings:
34 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2,055.00
(+6.55% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 22, 2026
EPS / Forecast
11.30 / 11.43
Revenue / Forecast
146.12B / 145.34B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 47.80%
Dividend Yield
0.83%
Industry Median 0.71%
Annualized payout
16.00
Paid annually
5-Years Growth
+16.36%
Growth Streak

SUN Income Statement

Compare SUN to Peers and Sector

Metrics to compare
SUN
Peers
Sector
Relationship
P/E Ratio
40.5x27.6x−0.4x
PEG Ratio
8.191.570.00
Price/Book
5.6x4.3x2.6x
Price / LTM Sales
7.9x3.9x3.0x
Upside (Analyst Target)
7.1%3.8%51.5%
Fair Value Upside
Unlock4.4%8.8%Unlock

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.

Employees
47000
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
534.93M22.30%1.04T
Other Institutional Investors
1.21B50.57%2.35T
Public Companies & Retail Investors
651.14M27.14%1.26T
Total
2.4B100.00%4.64T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Shanghvi Finance Pvt Ltd41.98%1,007,205,6921,949,446,617
Life Insurance Corporation of India4.93%118,316,554229,001,690

People Also Watch

269.40
VDAN
-1.16%
2,659.40
ASPN
-0.69%
958.95
HALC
-0.88%
1,232.00
REDY
-0.99%
10,247.50
BAJA
+0.90%

FAQ

What Is the Sun Pharma (SUN) Stock Price Today?

The Sun Pharma stock price today is 1,928.60 INR.

What Stock Exchange Does Sun Pharma Trade On?

Sun Pharma is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Sun Pharma?

The stock symbol for Sun Pharma is "SUN."

Does Sun Pharma Pay Dividends? What’s The Current Dividend Yield?

The Sun Pharma dividend yield is 0.83%.

What Is the Sun Pharma Market Cap?

As of today, Sun Pharma market cap is 4.62T INR.

What Is Sun Pharma's Earnings Per Share (TTM)?

The Sun Pharma EPS (TTM) is 47.80.

When Is the Next Sun Pharma Earnings Date?

Sun Pharma will release its next earnings report on Jul 31, 2026.

From a Technical Analysis Perspective, Is SUN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sun Pharma Stock Split?

Sun Pharma has split 5 times.

How Many Employees Does Sun Pharma Have?

Sun Pharma has 47000 employees.

What is the current trading status of Sun Pharma (SUN)?

As of Jul 13, 2026, Sun Pharma (SUN) is trading at a price of 1,928.60 INR, with a previous close of 1,935.50 INR. The stock has fluctuated within a day range of 1,911.00 INR to 1,933.10 INR, while its 52-week range spans from 1,548.00 INR to 1,953.90 INR.

What Is Sun Pharma (SUN) Price Target According to Analysts?

The average 12-month price target for Sun Pharma is 2,055.00 INR, with a high estimate of 2366 INR and a low estimate of 1650 INR. 30 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Buy. The stock has an +6.55% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.